UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

Psychopharmacology, 2013-01, Vol.225 (1), p.1-19

2013

Volltextzugriff (PDF)

An update of safety of clinically used atypical antipsychotics

Expert opinion on drug safety, 2016-10, Vol.15 (10), p.1329-1347

2016

Volltextzugriff (PDF)

Treating depression in patients with borderline personality disorder: clinical clues on the use of antidepressants

Annals of general psychiatry, 2024-05, Vol.23 (1), p.21-11, Article 21

2024

Volltextzugriff (PDF)

Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients

Journal of affective disorders, 2018-03, Vol.228, p.118-124

2018

Volltextzugriff (PDF)

A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice

Translational psychiatry, 2015-02, Vol.5 (2), p.e512-e512

2015

Volltextzugriff (PDF)

Schizophrenia is Associated with Elevated Amphetamine-Induced Synaptic Dopamine Concentrations: Evidence from a Novel Positron Emission Tomography Method

Proceedings of the National Academy of Sciences - PNAS, 1997-03, Vol.94 (6), p.2569-2574

1997

Volltextzugriff (PDF)

Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder

Neuropharmacology, 2017-07, Vol.121, p.179-194

2017

Volltextzugriff (PDF)

Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis

Current pharmaceutical design, 2005-10, Vol.11 (27), p.3561-3594

2005

Volltextzugriff (PDF)

C.14.02 Second witness – impact on brain architecture

European neuropsychopharmacology, 2015-09, Vol.25, p.S675-S675

De Bartolomeis, A

2015

Volltextzugriff (PDF)

The impact of affective temperaments on clinical and functional outcome of Bipolar I patients that initiated or changed pharmacological treatment for mania

Psychiatry research, 2018-03, Vol.261, p.473-480

2018

Volltextzugriff (PDF)

Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression

Journal of psychiatric research, 2021-04, Vol.136, p.522-528

2021

Volltextzugriff (PDF)

Does bipolar disorder differ from other mental illnesses in terms of emotion dysregulation? A systematic review and meta-analysis

EUROPEAN PSYCHIATRY, 2023-03, Vol.66 (S1), p.S571-S572

2023

Volltextzugriff (PDF)

Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice

Molecular brain, 2015-08, Vol.8 (1), p.47-47, Article 47

2015

Volltextzugriff (PDF)

Haloperidol modulates functional connectivity in the glutamate system: a postsynaptic density immediate-early gene-based network approach

European neuropsychopharmacology, 2016-10, Vol.26, p.S224-S225

2016

Volltextzugriff (PDF)

Analysis of Homer1a expression levels as a tool to investigate antipsychotic-related perturbation of synaptic plasticity: translational implications for schizophrenia treatment strategies

European neuropsychopharmacology, 2016-10, Vol.26, p.S233-S233

2016

Volltextzugriff (PDF)

Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder

Brain stimulation, 2017-03, Vol.10 (2), p.525-525

2017

Volltextzugriff (PDF)

Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: Implication for glutamatergic postsynaptic density in antipsychotics action

Neuroscience, 2007-11, Vol.150 (1), p.144-158

2007

Volltextzugriff (PDF)

P.1.009 Effects of caffeine, nicotine and their combination with haloperidol on PSD molecules: relevance to psychiatric diseases

European neuropsychopharmacology, 2016-03, Vol.26, p.S10-S11

2016

Volltextzugriff (PDF)

Does the " Silver Bullet " Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients

Clinical practice and epidemiology in mental health, 2016-12, Vol.12 (1), p.142-157

2016

Volltextzugriff (PDF)

P.3.c.008 Immediate early and constitutive genes expression in antipsychotic switching paradigm: from clinical practice to animal model

European neuropsychopharmacology, 2014-10, Vol.24, p.S519-S519

2014

Volltextzugriff (PDF)

The interplay among psychopathology, personal resources, context‐related factors and real‐life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non‐recovered patients

World psychiatry, 2020-02, Vol.19 (1), p.81-91

2020

Volltextzugriff (PDF)

Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition

Acta psychiatrica Scandinavica, 2018-09, Vol.138 (3), p.253-266

2018

Volltextzugriff (PDF)

Worse Comes to Worst in Schizophrenia: Treatment Resistant Schizophrenia Patients Show Greater Impairment in Functional Milestones of Everyday Living Compared to Other Psychiatric Disabling Conditions

European psychiatry, 2015-03, Vol.30, p.1754-1754

2015

Volltextzugriff (PDF)

1 – 25 von 404

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(331)
Mit Volltextzugriff
(336)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

An update of safety of clinically used atypical antipsychotics

Treating depression in patients with borderline personality disorder: clinical clues on the use of antidepressants

Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients

A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice

Schizophrenia is Associated with Elevated Amphetamine-Induced Synaptic Dopamine Concentrations: Evidence from a Novel Positron Emission Tomography Method

Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder

Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis

C.14.02 Second witness – impact on brain architecture

The impact of affective temperaments on clinical and functional outcome of Bipolar I patients that initiated or changed pharmacological treatment for mania

Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression

Does bipolar disorder differ from other mental illnesses in terms of emotion dysregulation? A systematic review and meta-analysis

Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice

Haloperidol modulates functional connectivity in the glutamate system: a postsynaptic density immediate-early gene-based network approach

Analysis of Homer1a expression levels as a tool to investigate antipsychotic-related perturbation of synaptic plasticity: translational implications for schizophrenia treatment strategies

Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder

Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: Implication for glutamatergic postsynaptic density in antipsychotics action

P.1.009 Effects of caffeine, nicotine and their combination with haloperidol on PSD molecules: relevance to psychiatric diseases

Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis

Does the " Silver Bullet " Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients

P.3.c.008 Immediate early and constitutive genes expression in antipsychotic switching paradigm: from clinical practice to animal model

The interplay among psychopathology, personal resources, context‐related factors and real‐life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non‐recovered patients

Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses

Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition

Worse Comes to Worst in Schizophrenia: Treatment Resistant Schizophrenia Patients Show Greater Impairment in Functional Milestones of Everyday Living Compared to Other Psychiatric Disabling Conditions

Suchergebnisse filtern